According to these data, differential ADAM15 variants expression determines tumor aggressiveness and clinical outcome by different interactions with intracellular pathways; especially ADAM15B due to owning broadest repertoire of interplaying partners is correlated with tumor malignancy [20]. This evidence concerns the gene ADAM15 and neoplasm.